Adjusting for multiple prognostic factors in the analysis of randomised trials

BMC Medical Research Methodology

Volumn 13, Issue 1, 2013, Pages

  Kahan, Brennan C ^a   Morris, Tim P ^a  

^a MRC CLINICAL TRIALS UNIT   (United Kingdom)

Author keywords

Covariate adjusted analysis; Randomised controlled trial; Restricted randomisation; Stratified analysis; Stratified randomisation

Indexed keywords

ARTICLE; EPIDEMIOLOGY; HUMAN; METHODOLOGY; MULTIVARIATE ANALYSIS; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); STATISTICS; THEORETICAL MODEL;

EPIDEMIOLOGIC FACTORS; HUMANS; MODELS, THEORETICAL; MULTIVARIATE ANALYSIS; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; STATISTICS AS TOPIC;

EID: 84880868718     PISSN: None     EISSN: 14712288     Source Type: Journal    
DOI: 10.1186/1471-2288-13-99     Document Type: Article

References (32)

1. Covariate adjustment in randomized controlled trials with dichotomous outcomes increases statistical power and reduces sample size requirements. Hernandez AV, Steyerberg EW, Habbema JD, J Clin Epidemiol 2004 57 5 454 460 10.1016/j.jclinepi.2003.09.014 15196615 (Pubitemid 38758048)
2. Covariate adjustment increased power in randomized controlled trials: an example in traumatic brain injury. Turner EL, Perel P, Clayton T, Edwards P, Hernandez AV, Roberts I, Shakur H, Steyerberg EW, J Clin Epidemiol 2012 65 5 474 481 10.1016/j.jclinepi.2011.08.012 22169080
3. Senn S, Statistical issues in drug development Chichester: Wiley 2007
4. Randomized controlled trials with time-to-event outcomes: how much does prespecified covariate adjustment increase power? Hernandez AV, Eijkemans MJ, Steyerberg EW, Ann Epidemiol 2006 16 1 41 48 10.1016/j.annepidem.2005.09.007 16275011 (Pubitemid 41783887)
5. Adjustment for strong predictors of outcome in traumatic brain injury trials: 25% reduction in sample size requirements in the IMPACT study. Hernandez AV, Steyerberg EW, Butcher I, Mushkudiani N, Taylor GS, Murray GD, Marmarou A, Choi SC, Lu J, Habbema JD, et al. J Neurotrauma 2006 23 9 1295 1303 10.1089/neu.2006.23.1295 16958582 (Pubitemid 46489616)
6. A simulation study evaluating approaches to the analysis of ordinal outcome data in randomized controlled trials in traumatic brain injury: results from the IMPACT project. McHugh GS, Butcher I, Steyerberg EW, Marmarou A, Lu J, Lingsma HF, Weir J, Maas AI, Murray GD, Clin Trials 2010 7 1 44 57 10.1177/1740774509356580 20156956
7. The effect of omitted covariates on confidence interval and study power in binary outcome analysis: a simulation study. Negassa A, Hanley JA, Contemp Clin Trials 2007 28 3 242 248 10.1016/j.cct.2006.08.007 17011835 (Pubitemid 46330167)
8. Reporting on covariate adjustment in randomised controlled trials before and after revision of the 2001 CONSORT statement: a literature review. Yu LM, Chan AW, Hopewell S, Deeks JJ, Altman DG, Trials 2010 11 59 10.1186/1745-6215- 11-59 20482769
9. Improper analysis of trials randomised using stratified blocks or minimisation. Kahan BC, Morris TP, Stat Med 2012 31 4 328 340 10.1002/sim.4431 22139891
10. Reporting and analysis of trials using stratified randomisation in leading medical journals: review and reanalysis. Kahan BC, Morris TP, BMJ 2012 345 5840 10.1136/bmj.e5840 22983531
11. Does clustering affect the usual test statistics of no treatment effect in a randomized clinical trial? Parzen M, Lipsitz SR, Dear KBG, Biom J 1998 40 385 402 10.1002/(SICI)1521-4036(199808)40:4<385::AID-BIMJ385>3.0.CO;2-#
12. Assessing potential sources of clustering in individually randomised trials. Kahan BC, Morris TP, BMC Med Res Methodol 2013 13 1 58 10.1186/1471-2288-13-58 23590245
13. Comparison of stratification and adaptive methods for treatment allocation in an acute stroke clinical trial. Weir CJ, Lees KR, Stat Med 2003 22 5 705 726 10.1002/sim.1366 12587101 (Pubitemid 36266962)
14. Analysis of multicentre trials with continuous outcomes: when and how should we account for centre effects? Kahan BC, Morris TP, Stat Med 2013 32 7 1136 1149 10.1002/sim.5667 23112128
15. Rosenberger WF, Lachin JM, Randomization in clinical trials: theory and practice New York: John Wiley & Sons, Inc. 2002
16. Rank minimization with a two-step analysis should not replace randomization in clinical trials. Kahan BC, J Clin Epidemiol 2012 65 7 808 809 22564501
17. Strategies for comparing treatments on a binary response with multi-centre data. Agresti A, Hartzel J, Stat Med 2000 19 8 1115 1139 10.1002/(SICI)1097-0258(20000430)19:8<1115::AID-SIM408>3.0.CO;2-X 10790684 (Pubitemid 30238919)
18. The analysis of continuous outcomes in multi-centre trials with small centre sizes. Pickering RM, Weatherall M, Stat Med 2007 26 30 5445 5456 10.1002/sim.3068 17924360 (Pubitemid 351193573)
19. Comparing methods to estimate treatment effects on a continuous outcome in multicentre randomized controlled trials: a simulation study. Chu R, Thabane L, Ma J, Holbrook A, Pullenayegum E, Devereaux PJ, BMC Med Res Methodol 2011 11 21 10.1186/1471-2288-11-21 21338524
20. Adjustments for center in multicenter studies: an overview. Localio AR, Berlin JA, Ten Have TR, Kimmel SE, Ann Intern Med 2001 135 2 112 123 10.7326/0003-4819-135-2-200107170-00012 11453711 (Pubitemid 32661194)
21. Modelling clustered survival data from multicentre clinical trials. Glidden DV, Vittinghoff E, Stat Med 2004 23 3 369 388 10.1002/sim.1599 14748034 (Pubitemid 38180794)
22. Estimation of covariate effects in generalized linear mixed models with a misspecified distribution of random intercepts and slopes. Neuhaus JM, McCulloch CE, Boylan R, Stat Med 2013 32 14 2419 2429 10.1002/sim.5682 23203817
23. Should we adjust for covariates in nonlinear regression analyses of randomized trials? Hauck WW, Anderson S, Marcus SM, Control Clin Trials 1998 19 3 249 256 10.1016/S0197-2456(97)00147-5 9620808 (Pubitemid 28255120)
24. Some surprising results about covariate adjustment in logistic regression models. Robinson LD, Jewell NP, Int Stat Rev 1991 58 227 240
25. Intrapleural use of tissue plasminogen activator and DNase in pleural infection. Rahman NM, Maskell NA, West A, Teoh R, Arnold A, Mackinlay C, Peckham D, Davies CW, Ali N, Kinnear W, et al. N Engl J Med 2011 365 6 518 526 10.1056/NEJMoa1012740 21830966
26. Bias in randomised factorial trials. Kahan BC, Stat Med 2013 10.1002/sim.5869
27. Outcomes following acute nonvariceal upper gastrointestinal bleeding in relation to time to endoscopy: results from a nationwide study. Jairath V, Kahan BC, Logan RF, Hearnshaw SA, Dore CJ, Travis SP, Murphy MF, Palmer KR, Endoscopy 2012 44 8 723 730 22752889
28. National audit of the use of surgery and radiological embolization after failed endoscopic haemostasis for non-variceal upper gastrointestinal bleeding. Jairath V, Kahan BC, Logan RF, Hearnshaw SA, Dore CJ, Travis SP, Murphy MF, Palmer KR, Br J Surg 2012 99 12 1672 1680 10.1002/bjs.8932 23023268
29. Mortality from acute upper gastrointestinal bleeding in the United Kingdom: does it display a "weekend effect"? Jairath V, Kahan BC, Logan RF, Hearnshaw SA, Travis SP, Murphy MF, Palmer KR, Am J Gastroenterol 2011 106 9 1621 1628 10.1038/ajg.2011.172 21606977
30. Prevalence, management, and outcomes of patients with coagulopathy after acute nonvariceal upper gastrointestinal bleeding in the United Kingdom. Jairath V, Kahan BC, Stanworth SJ, Logan RF, Hearnshaw SA, Travis SP, Palmer KR, Murphy MF, Transfusion 2012 53 5 1069 1076 22897615
31. Beneficial effect of azathioprine and prediction of prognosis in primary biliary cirrhosis. Final results of an international trial. Christensen E, Neuberger J, Crowe J, Altman DG, Popper H, Portmann B, Doniach D, Ranek L, Tygstrup N, Williams R, Gastroenterology 1985 89 5 1084 1091 3899841 (Pubitemid 16231574)
32. Generating survival times to simulate Cox proportional hazards models. Bender R, Augustin T, Blettner M, Stat Med 2005 24 11 1713 1723 10.1002/sim.2059 15724232 (Pubitemid 40754090)